New England Biolabs® has announced the launch of the SARS-CoV-2 Rapid Colorimetric LAMP Assay Kit, a Research Use Only (RUO) product that can be used for the visual detection of SARS-CoV-2 RNA.

Cancer Research UK and Abcam plc have announced a new partnership for the development and commercialization of novel custom antibodies to support the acceleration of cancer research.

Luminex Corporation has announced that the company has submitted an Emergency Use Authorization request to the U.S. Food and Drug Administration (FDA) for its xMAP® SARS-CoV-2 Multi-Antigen IgG assay.

An advanced laboratory dedicated to leading Wales’ national COVID-19 testing has been established in Cardiff, thanks to collaboration between Public Health Wales and one of the world’s leading diagnostics companies.

Codexis, Inc., a leading protein engineering company and developer of high-performance enzymes, and Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, announce a partnership to engineer enzymes to deliver differentiated and cost-effective solutions for the enzymatic synthesis of DNA.

Avacta has announced that the first Affimer-based rapid test strips to detect SARS-COV-2 spike protein have been developed, evaluated and show positive initial performance data.

Kerafast Inc. has announced the availability of the Delta-G-VSV Pseudotyping System for coronavirus research applications, enabling studies of SARS-CoV-2 viral entry and COVID-19 vaccine effectiveness at just biosafety level 2 containment.

Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, announced progress on late-stage development of mRNA-1273, the Company’s mRNA vaccine candidate against COVID-19.

GSK’s scientific collaboration with Clover Pharmaceuticals to develop an adjuvanted COVID-19 vaccine has entered into human clinical trials.

Postnova Analytics has published a new white paper that details how multi-detector Asymmetrical Field Flow Fractionation (AF4) and Electrical AF4 (EAF4) techniques are transforming the separation and characterization of viruses and antibodies.